Home > Insider Trading > Filing (0001140361-13-004709)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377232	Phd J Michael Williams	One Idexx Drive Westbrook ME 04092	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-01	7,668	$53.31	17,696	No	4	M	Direct
Common Stock	Acquisiton	2013-02-01	15,764	$56.95	33,460	No	4	M	Direct
Common Stock	Disposition	2013-02-01	23,432	$94.68	10,028	No	4	S	Direct
Common Stock	Disposition	2013-02-01	862	$94.96	9,166	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2013-02-01	7,668	$0.00	7,668	$53.31
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2013-02-01	15,764	$0.00	15,764	$56.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,627		2017-02-13	No	4	M	Direct
2,186		2015-02-13	No	4	M	Direct

Footnotes

Includes 63 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2012.
Grant of options to buy shares of common stock becomes exercisable as to 3,834 shares on 02/14/2011, 02/14/2012, 02/14/2013 and 02/14/2014 and the remaining 1,959 shares on 02/14/2015.
Grant of options to buy shares of common stock becomes exercisable as to 3,942 shares on 02/14/2009, 3,941 shares on 02/14/2010 and 02/14/2012, 3,940 shares on 02/14/2011 and the remaining 2,186 shares on 02/14/2013.